Trial Profile
Investigation on Appropriate Duration of Dabigatran Use After Catheter Ablation for Paroxysmal Atrial Fibrillation in Patients With Low Thromboembolic Risk
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 07 Sep 2017
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary)
- Indications Thromboembolism
- Focus Therapeutic Use
- 16 Dec 2014 New trial record